CO4910129A1 - PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF N-SULFONIL INDOLINA - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF N-SULFONIL INDOLINAInfo
- Publication number
- CO4910129A1 CO4910129A1 CO97071118A CO97071118A CO4910129A1 CO 4910129 A1 CO4910129 A1 CO 4910129A1 CO 97071118 A CO97071118 A CO 97071118A CO 97071118 A CO97071118 A CO 97071118A CO 4910129 A1 CO4910129 A1 CO 4910129A1
- Authority
- CO
- Colombia
- Prior art keywords
- amphiphilic
- indolina
- sulfonil
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Sistema solubilizante/estabilizanteanhidro, emulsionable o microemulsionable en agua, para la solubilización de los derivados hidrófobos de N-sulfonil indolina de fórmula: caracterizado porque comprende uno o varios constituyentes elegidos entre compuestos anfífilos, agentes tensioactivos hidrófobos no iónicos y compuestos hidrófilos no iónicos dotados a la vez de propiedades anfifilas y tensioactivas, entendiéndose que dicho sistema comprende ya sea al menos una mezcla de un compuesto anfifilo y un agente tensioactivo hidrófilo no iónico, ya sea al menos un compuesto hidrófilo no iónico dotado a la vez de propiedades tensioactivas y anfífilas.Anhydrous solubilizing / stabilizing system, emulsifiable or microemulsifiable in water, for the solubilization of the hydrophobic derivatives of N-sulfonyl indoline of formula: characterized in that it comprises one or more constituents chosen from amphiphilic compounds, nonionic hydrophobic surfactants and nonionic hydrophilic compounds endowed with both amphiphilic and surfactant properties, it being understood that said system comprises either at least a mixture of an amphiphilic compound and a nonionic hydrophilic surfactant, or at least one nonionic hydrophilic compound endowed with both surfactant and amphiphilic properties.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9614957A FR2756736B1 (en) | 1996-12-05 | 1996-12-05 | PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4910129A1 true CO4910129A1 (en) | 2000-04-24 |
Family
ID=9498376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO97071118A CO4910129A1 (en) | 1996-12-05 | 1997-12-04 | PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF N-SULFONIL INDOLINA |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0941090A1 (en) |
| JP (1) | JP2000507618A (en) |
| KR (1) | KR20000069308A (en) |
| CN (1) | CN1239887A (en) |
| AR (1) | AR009651A1 (en) |
| AU (1) | AU716575B2 (en) |
| BR (1) | BR9712406A (en) |
| CA (1) | CA2273990A1 (en) |
| CO (1) | CO4910129A1 (en) |
| DZ (1) | DZ2362A1 (en) |
| EE (1) | EE9900206A (en) |
| FR (1) | FR2756736B1 (en) |
| HU (1) | HUP0001386A3 (en) |
| ID (1) | ID23373A (en) |
| IL (1) | IL129936A0 (en) |
| IS (1) | IS5062A (en) |
| MY (1) | MY132819A (en) |
| NO (1) | NO992724D0 (en) |
| NZ (1) | NZ335750A (en) |
| RU (1) | RU2174394C2 (en) |
| SK (1) | SK75599A3 (en) |
| TR (1) | TR199901702T2 (en) |
| WO (1) | WO1998024430A1 (en) |
| YU (1) | YU23099A (en) |
| ZA (1) | ZA9710919B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786486B3 (en) * | 1998-11-16 | 2000-12-08 | Sanofi Sa | PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES |
| DE19913692A1 (en) * | 1999-03-25 | 2000-09-28 | Basf Ag | Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances |
| US6437006B1 (en) | 1999-09-27 | 2002-08-20 | American Cyanamid Company | Pharmaceutical carrier formulation |
| WO2001034119A2 (en) | 1999-11-12 | 2001-05-17 | Abbott Laboratories | Inhibitors of crystallization in a solid dispersion |
| FR2805992A1 (en) * | 2000-03-08 | 2001-09-14 | Sanofi Synthelabo | Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability |
| DE10026698A1 (en) | 2000-05-30 | 2001-12-06 | Basf Ag | Self-emulsifying active ingredient formulation and use of this formulation |
| ITMI20011338A1 (en) * | 2001-06-26 | 2002-12-26 | Farmatron Ltd | ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT |
| US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
| UA119324C2 (en) * | 2013-04-02 | 2019-06-10 | Теміс Медікер Лімітед | Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives |
| KR102139339B1 (en) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | Cosmetic composition which has improved solubility comprising indole compound |
| KR102139338B1 (en) * | 2013-06-24 | 2020-07-29 | 주식회사 엘지생활건강 | Cosmetic composition which has improved solubility comprising indole compound |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3237814A1 (en) * | 1982-10-12 | 1984-04-12 | Warner-Lambert Co., 07950 Morris Plains, N.J. | WATER-FREE EMULSIONS AND USE THEREOF |
| FR2679903B1 (en) * | 1991-08-02 | 1993-12-03 | Elf Sanofi | DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. |
-
1996
- 1996-12-05 FR FR9614957A patent/FR2756736B1/en not_active Expired - Fee Related
-
1997
- 1997-12-03 DZ DZ970212A patent/DZ2362A1/en active
- 1997-12-04 CA CA002273990A patent/CA2273990A1/en not_active Abandoned
- 1997-12-04 HU HU0001386A patent/HUP0001386A3/en unknown
- 1997-12-04 IL IL12993697A patent/IL129936A0/en unknown
- 1997-12-04 JP JP10525294A patent/JP2000507618A/en active Pending
- 1997-12-04 SK SK755-99A patent/SK75599A3/en unknown
- 1997-12-04 AR ARP970105696A patent/AR009651A1/en unknown
- 1997-12-04 EE EEP199900206A patent/EE9900206A/en unknown
- 1997-12-04 ID IDW990445D patent/ID23373A/en unknown
- 1997-12-04 BR BR9712406-0A patent/BR9712406A/en unknown
- 1997-12-04 KR KR1019997004983A patent/KR20000069308A/en not_active Application Discontinuation
- 1997-12-04 RU RU99114019/14A patent/RU2174394C2/en active
- 1997-12-04 WO PCT/FR1997/002210 patent/WO1998024430A1/en not_active Application Discontinuation
- 1997-12-04 AU AU53262/98A patent/AU716575B2/en not_active Ceased
- 1997-12-04 TR TR1999/01702T patent/TR199901702T2/en unknown
- 1997-12-04 EP EP97950228A patent/EP0941090A1/en not_active Withdrawn
- 1997-12-04 MY MYPI97005848A patent/MY132819A/en unknown
- 1997-12-04 CO CO97071118A patent/CO4910129A1/en unknown
- 1997-12-04 ZA ZA9710919A patent/ZA9710919B/en unknown
- 1997-12-04 CN CN97180304A patent/CN1239887A/en active Pending
- 1997-12-04 NZ NZ335750A patent/NZ335750A/en unknown
-
1999
- 1999-05-26 YU YU23099A patent/YU23099A/en unknown
- 1999-06-01 IS IS5062A patent/IS5062A/en unknown
- 1999-06-04 NO NO992724A patent/NO992724D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TR199901702T2 (en) | 1999-09-21 |
| NO992724L (en) | 1999-06-04 |
| CA2273990A1 (en) | 1998-06-11 |
| WO1998024430A1 (en) | 1998-06-11 |
| CN1239887A (en) | 1999-12-29 |
| RU2174394C2 (en) | 2001-10-10 |
| YU23099A (en) | 1999-11-22 |
| FR2756736B1 (en) | 1999-03-05 |
| MY132819A (en) | 2007-10-31 |
| SK75599A3 (en) | 2000-08-14 |
| ID23373A (en) | 2000-04-20 |
| HUP0001386A3 (en) | 2002-03-28 |
| FR2756736A1 (en) | 1998-06-12 |
| NO992724D0 (en) | 1999-06-04 |
| NZ335750A (en) | 2001-06-29 |
| EP0941090A1 (en) | 1999-09-15 |
| DZ2362A1 (en) | 2002-12-28 |
| HUP0001386A2 (en) | 2001-04-28 |
| AU716575B2 (en) | 2000-03-02 |
| KR20000069308A (en) | 2000-11-25 |
| AU5326298A (en) | 1998-06-29 |
| EE9900206A (en) | 1999-12-15 |
| JP2000507618A (en) | 2000-06-20 |
| AR009651A1 (en) | 2000-04-26 |
| IS5062A (en) | 1999-06-01 |
| ZA9710919B (en) | 1999-06-04 |
| BR9712406A (en) | 1999-08-31 |
| IL129936A0 (en) | 2000-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4910129A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DERIVATIVES OF N-SULFONIL INDOLINA | |
| MX9301032A (en) | PHARMACEUTICAL COMPOUNDS AND PROCEDURE FOR THE PREPARATION | |
| BR9916132A (en) | Compositions and their use | |
| BR0017013A (en) | Azaldehyde antibiotic compositions | |
| NO933482L (en) | N-sulfonyl-2-oxoindole derivatives having affinity for vasopressin and / or ocytocin receptors | |
| HK1036931A1 (en) | Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients. | |
| PT975235E (en) | NUTRITIONAL FORMULATIONS CONTAINING OLIGOSACARIDOS | |
| EA200100105A1 (en) | SUBSTITUTED DERIVATIVES OF OXAZOLES AND THIAZOLES AS ACTIVATORS OF hPPAR GAMMA and hPPAR ALPHA | |
| CY1107506T1 (en) | METHOD FOR STABILIZATION OF VENZIMIDAZOLA UNION OF COMPOUNDS | |
| BR9914526A (en) | Adenine derivatives | |
| ATE233539T1 (en) | FOAM LIGHT PREPARATIONS CONTAINING WATER-SOLUBLE LIGHT PROTECTION SUBSTANCES AND SURFACE-ACTIVE SUBSTANCES | |
| AR011846A1 (en) | A PHARMACEUTICAL COMPOSITION, AND THE PROCEDURE TO PREPARE IT | |
| IL128345A (en) | Enhanced contrast agent for ultrasound imaging of the liver | |
| DE69732571D1 (en) | BETA-SULFONYL-HYDROXAMIC ACIDS AS MATRIX-METALLOPROTEINASEINHIBITORS | |
| ITMI931780A1 (en) | TROPIL 7-AZAINDOLIL-3-CARBOXYAMIDE | |
| NO943762L (en) | Indole derivatives such as 5-HT 1 agonists | |
| CO4340621A1 (en) | COMPLEXES OF INCLUSION IN AQUEOUS SOLUTION OF BENZOTIOFEN COMPOUNDS WITH WATER-SOLUBLE CYCLODEXTRINS AND THEIR PHARMACEUTICAL FORMULATIONS AND THEIR PROCEDURES | |
| DK0745388T3 (en) | Mammalian vaccine preparation comprising squalene or squalane, phospholipid and a surfactant as adjuvant | |
| ES2184787T3 (en) | OIL EMULSIONS IN WATER. | |
| RS50002B (en) | Eletriptan hydrobromide monohydrate | |
| ES2115053T3 (en) | INDOLIC DERIVATIVES INHIBITORS OF 5ALFA-REDUCTASE OF STEROIDS. | |
| ATE361931T1 (en) | N1 MODIFIED GLYCOPEPTIDES | |
| CO4750591A1 (en) | INSECT FIGHTING PROCEDURE | |
| BR9908796A (en) | Use of macrolide compounds, method of treatment and prevention of ards, pharmaceutical composition and macrolide compound | |
| ES2164168T3 (en) | ANTIGONISTS OF FIBRINOGEN RECEPTORS THAT HAVE SUBSTITUTED BETA-AMINOACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THE SAME. |